Explore Watchlists Pricing

REGENERON PHARMACEUTICALS, INC. (REGN) Balance sheet

Market cap

$80.5B

P/E ratio

18.4x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	113	484	230	536	649	809	535	813	1,480	1,630	2,207	2,898	3,119	2,738	2,489	3,124
Total cash & short-term investments	113	484	230	536	649	809	535	813	1,480	1,630	2,207	2,898	3,119	2,738	2,489	3,124
Accounts receivable, net	14	28	593	787	739	1,152	1,343	1,539	1,724	2,100	3,112	6,037	5,329	5,667	6,212	5,741
Inventories	-	-	-	70	129	239	399	726	1,151	1,416	1,917	1,951	2,402	2,581	3,087	3,201
Total current assets	358	653	1,206	1,797	2,167	2,915	3,180	4,335	6,448	7,689	9,779	14,015	15,884	19,479	18,661	18,022
Property, plant and equipment, net	347	368	380	527	974	1,594	2,083	2,359	2,576	-	-	-	-	-	-	-
Marketable securities, non-current	370	276	271	390	460	632	864	1,486	1,755	3,257	3,136	6,838	6,592	5,397	8,900	10,261
Total assets	1,089	1,324	2,080	2,951	3,872	5,609	6,973	8,764	11,735	14,805	17,163	25,435	29,215	33,080	37,759	40,559
Accounts payable	-	-	-	-	-	-	-	-	218	418	476	564	589	607	790	939
Total current liabilities	109	148	164	299	655	811	1,241	1,135	1,443	2,097	2,697	3,933	3,141	3,423	3,944	4,368
Long-term debt, non-current	-	-	-	-	-	-	-	-	-	-	1,979	1,980	1,981	1,983	1,984	1,986
Total liabilities	562	838	835	999	1,330	1,954	2,524	2,620	2,977	3,716	6,138	6,666	6,551	7,107	8,406	9,302
Retained earnings	-1,046	-1,267	-517	-93	255	853	1,748	2,947	5,254	7,380	10,893	18,968	23,307	27,260	31,673	35,797
Stockholders' equity	528	486	1,245	1,952	2,542	3,655	4,449	6,144	8,757	11,090	11,025	18,769	22,664	25,973	29,354	31,257
Working capital	-	-	-	-	-	-	-	-